Insufficient scRNA-seq data for expression of MESP2 at single-cell level.
Insufficient scRNA-seq data for expression of MESP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 97% | 36.80 | 444 / 459 | 73% | 4.48 | 818 / 1118 |
prostate | 87% | 23.71 | 213 / 245 | 82% | 3.13 | 410 / 502 |
skin | 90% | 17.93 | 1632 / 1809 | 28% | 0.61 | 133 / 472 |
brain | 98% | 41.73 | 2588 / 2642 | 12% | 0.21 | 88 / 705 |
adrenal gland | 87% | 18.67 | 225 / 258 | 19% | 0.51 | 43 / 230 |
bladder | 67% | 6.57 | 14 / 21 | 36% | 1.70 | 183 / 504 |
esophagus | 55% | 12.61 | 788 / 1445 | 48% | 2.05 | 88 / 183 |
intestine | 64% | 20.08 | 614 / 966 | 38% | 1.10 | 202 / 527 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.28 | 1 / 1 |
pancreas | 62% | 7.28 | 202 / 328 | 37% | 0.78 | 65 / 178 |
uterus | 22% | 2.85 | 37 / 170 | 76% | 5.74 | 350 / 459 |
ovary | 22% | 2.17 | 39 / 180 | 75% | 3.28 | 324 / 430 |
thymus | 75% | 11.72 | 488 / 653 | 20% | 0.44 | 118 / 605 |
kidney | 63% | 12.67 | 56 / 89 | 31% | 1.15 | 282 / 901 |
liver | 36% | 3.77 | 81 / 226 | 57% | 2.07 | 233 / 406 |
adipose | 91% | 22.30 | 1096 / 1204 | 0% | 0 | 0 / 0 |
lung | 32% | 3.81 | 186 / 578 | 47% | 1.98 | 548 / 1155 |
stomach | 31% | 3.19 | 113 / 359 | 37% | 0.96 | 107 / 286 |
tonsil | 0% | 0 | 0 / 0 | 67% | 3.16 | 30 / 45 |
heart | 58% | 7.35 | 496 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 36% | 4.64 | 483 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.62 | 5 / 29 |
muscle | 17% | 1.52 | 133 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 16% | 0.29 | 13 / 80 |
peripheral blood | 14% | 1.55 | 134 / 929 | 0% | 0 | 0 / 0 |
spleen | 12% | 0.97 | 28 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001707 | Biological process | mesoderm formation |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0003007 | Biological process | heart morphogenesis |
GO_0032525 | Biological process | somite rostral/caudal axis specification |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | MESP2 |
Protein name | Mesoderm posterior bHLH transcription factor 2 Mesoderm posterior protein 2 (Class C basic helix-loop-helix protein 6) (bHLHc6) |
Synonyms | BHLHC6 SCDO2 |
Description | FUNCTION: Transcription factor with important role in somitogenesis. Defines the rostrocaudal patterning of the somite by participating in distinct Notch pathways. Regulates also the FGF signaling pathway. Specifies the rostral half of the somites. Generates rostro-caudal polarity of somites by down-regulating in the presumptive rostral domain DLL1, a Notch ligand. Participates in the segment border formation by activating in the anterior presomitic mesoderm LFNG, a negative regulator of DLL1-Notch signaling. Acts as a strong suppressor of Notch activity. Together with MESP1 is involved in the epithelialization of somitic mesoderm and in the development of cardiac mesoderm. |
Accessions | ENST00000341735.5 H0YKZ5 Q0VG99 ENST00000560219.2 |